Brain-Derived Neurotrophic Factor: A Newly Described Mediator of Angiogenesis

Trends in Cardiovascular Medicine

Volumn 17, Issue 4, 2007, Pages 140-143

  Kermani, Pouneh ^a   Hempstead, Barbara ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; PROTEIN TYROSINE KINASE A; TYROSINE KINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; CLINICAL TRIAL; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; GENE DUPLICATION; HEART BLOOD VESSEL; HEART DISEASE; HUMAN; ISCHEMIA; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; SKIN;

ANGIOGENESIS INDUCING AGENTS; BONE MARROW CELLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, TRKB; REGENERATION;

EID: 34247647524     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.03.002     Document Type: Review

References (31)

1. Bibel M., and Barde Y. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14 (2000) 2919-2937
2. Botchkarev VA., Metz M., Botchkareva NV., et al. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 act as "epitheliotrophins" in murine skin. Lab Invest 79 (1999) 557-572
3. Cantarella G., Lempereur L., Presta M., et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16 (2002) 1307-1309
4. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
5. Coppola V., Barrick C.A., Southon E.A., et al. Ablation of TrkA function in the immune system causes B cell abnormalities. Development 131 (2004) 5185-5195
6. Dolle J.P., Rezvan A., Allen F.D., et al. Nerve growth factor-induced migration of endothelial cells. J Pharmacol Exp Ther 315 (2005) 1220-1227
7. Donovan M.J., Lin M.I., Wiegn P., et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127 (2000) 4531-4540
8. Emanueli C., Salis M.B., Pinna A., et al. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106 (2002) 2257-2262
9. Epstein S.E., Fuchs S., Zhou Y.F., et al. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 49 (2001) 532-542
10. Frade J.M., and Barde Y.A. Nerve growth factor: two receptors, multiple functions. Bioessays 20 (1998) 137-145
11. Garlanda C., and Dejana E. Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17 (1997) 1193-1202
12. Hallbook F., Wilson K., Thorndyke M., and Olinski R.P. Formation and evolution of the chordate neurotrophin and Trk receptor genes. Brain Behav Evol 68 (2006) 133-144
13. Hempstead B.L. The many faces of p75NTR. Curr Opin Neurobiol 12 (2002) 260-267
14. Huang E.J., and Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72 (2003) 609-642
15. Isner J.M., Vale P.R., Symes J.F., and Losordo D.W. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 89 (2001) 389-400
16. Kaplan D.R., and Miller F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10 (2000) 381-391
17. + endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest 115 (2005) 653-663
18. Kraemer R. Reduced apoptosis and increased lesion development in the flow-restricted carotid artery of p75(NTR)-null mutant mice. Circ Res 91 (2002) 494-500
19. Lee R., Kermani P., Teng K.K., and Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 294 (2001) 1945-1948
20. Lin M.I., Das I., Schwartz G.M., et al. TrkC receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo. Dev Biol 226 (2000) 180-191
21. Lu B., Pang P.T., and Woo N.H. The yin and yang of neurotrophin action. Nat Rev Neurosci 6 (2005) 603-614
22. Nemoto K., Fukamachi K., Nemoto F., et al. Gene expression of neurotrophins and their receptors in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 245 (1998) 284-288
23. Nykjaer A., Lee R., Teng K.K., et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427 (2004) 843-848
24. Paul C.E., Vereker E., Dickson K.M., and Barker P.A. A proapoptotic fragment of the p75 neurotrophin receptor is expressed in p75NTR exonIV null mice. J Neurosci 24 (2004) 1917-1923
25. Robson S.C., Kaczmarek E., Siegel J.B., et al. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185 (1997) 153-163
26. Storkebaum E., Lambrechts D., and Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26 (2004) 943-954
27. Tessarollo L., Tsoulfas P., Donovan M.J., et al. Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. Proc Natl Acad Sci U S A 94 (1997) 14776-14781
28. Turrin P., Gaetano C., Antonelli A., et al. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci Lett 323 (2002) 109-112
29. Urbich C., Dernbach E., Aicher A., et al. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106 (2002) 981-986
30. Von Schack D., Casademunt E., Schweigreiter R., et al. Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system. Nat Neurosci 4 (2001) 977-978
31. Wagner N., Wagner K.D., Theres H., et al. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev 19 (2005) 2631-2642